ETBRIUN Trademark Information

Trademark by Glaxo Group Limited

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncolog...

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: ETBRIUN
Status/Status Date:
SECOND EXTENSION - GRANTED
2/2/2021
Serial Number: 88399563
Filing Date: 4/24/2019
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 1/7/2020
Last Applicant/Owner:
Glaxo Group Limited
Brentford, Middlesex TW89GS
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
GSK
LBP, 5.5A
5 MOORE DRIVE
RESEARCH TRIANGLE PARK NC 27709-3398
Current Status:
SECOND EXTENSION - GRANTED
2/2/2021
Correspondent Search:
MERILEE J. AREVALO is a correspondent of ETBRIUN trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on